Effect of acetylsalicylic acid on nuclear factor-κB activation and on late preconditioning against infarction in the myocardium

Gabor Jancso, Barbara Cserepes, B. Gasz, Laszlo Benko, A. Ferencz, B. Borsiczky, J. Lantos, Anjali Dureja, Katalin Kiss, J. Szeberényi, E. Rőth

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Nuclear factor-κB (NF-κB) plays an essential role in the intracellular signal transduction of the second window of protection (SWOP). Acetylsalicylic acid (ASA) blocks NF-κB-dependent gene activation in leukocytes and endothelial cells through preventing phosphorylation and subsequent degradation of the inhibitor IκB-α. This study investigated the effect of ASA on the late phase of ischemic preconditioning (PC) against myocardial infarction and on the activation of NF-κB in the preconditioned myocardium. Conscious rabbits were subjected to 4 cycles of 5 minutes of coronary occlusion and 5 minutes of reperfusion together with 3 different doses of ASA (5 mg/kg; 25 mg/kg; 130 mg/kg). After 30 minutes of reperfusion we determined the activation of NF-κB with an electrophoretic mobility shift assay (EMSA). Twenty-four hours later, after 30 minutes of test ischemia, we performed infarct size analysis using triphenyltetrazolium-chloride (TTC) staining. Neither 5 mg/kg (antithrombotic dose) nor 25 mg/kg (analgesic/antipyretic dose) of ASA interfered with the NF-κB activation and the protective effect of late preconditioning against myocardial infarction. In contrast, NF-κB activation and late PC effect were completely abrogated by 130 mg/kg of ASA. Our results suggest that nonselective doses of NSAIDs should be used with caution in patients with atherosclerotic cardiovascular disease because they may deprive the heart of its innate defensive response.

Original languageEnglish
Pages (from-to)295-301
Number of pages7
JournalJournal of Cardiovascular Pharmacology
Volume46
Issue number3
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Infarction
Aspirin
Myocardium
Reperfusion
Myocardial Infarction
Antipyretics
Ischemic Preconditioning
Coronary Occlusion
Electrophoretic Mobility Shift Assay
Non-Steroidal Anti-Inflammatory Agents
Transcriptional Activation
Analgesics
Signal Transduction
Leukocytes
Cardiovascular Diseases
Ischemia
Endothelial Cells
Phosphorylation
Staining and Labeling
Rabbits

Keywords

  • Acetylsalicylic acid
  • Delayed preconditioning
  • NF-κB

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Effect of acetylsalicylic acid on nuclear factor-κB activation and on late preconditioning against infarction in the myocardium. / Jancso, Gabor; Cserepes, Barbara; Gasz, B.; Benko, Laszlo; Ferencz, A.; Borsiczky, B.; Lantos, J.; Dureja, Anjali; Kiss, Katalin; Szeberényi, J.; Rőth, E.

In: Journal of Cardiovascular Pharmacology, Vol. 46, No. 3, 09.2005, p. 295-301.

Research output: Contribution to journalArticle

@article{37a5de189cb9496e89e49ad46807a6a0,
title = "Effect of acetylsalicylic acid on nuclear factor-κB activation and on late preconditioning against infarction in the myocardium",
abstract = "Nuclear factor-κB (NF-κB) plays an essential role in the intracellular signal transduction of the second window of protection (SWOP). Acetylsalicylic acid (ASA) blocks NF-κB-dependent gene activation in leukocytes and endothelial cells through preventing phosphorylation and subsequent degradation of the inhibitor IκB-α. This study investigated the effect of ASA on the late phase of ischemic preconditioning (PC) against myocardial infarction and on the activation of NF-κB in the preconditioned myocardium. Conscious rabbits were subjected to 4 cycles of 5 minutes of coronary occlusion and 5 minutes of reperfusion together with 3 different doses of ASA (5 mg/kg; 25 mg/kg; 130 mg/kg). After 30 minutes of reperfusion we determined the activation of NF-κB with an electrophoretic mobility shift assay (EMSA). Twenty-four hours later, after 30 minutes of test ischemia, we performed infarct size analysis using triphenyltetrazolium-chloride (TTC) staining. Neither 5 mg/kg (antithrombotic dose) nor 25 mg/kg (analgesic/antipyretic dose) of ASA interfered with the NF-κB activation and the protective effect of late preconditioning against myocardial infarction. In contrast, NF-κB activation and late PC effect were completely abrogated by 130 mg/kg of ASA. Our results suggest that nonselective doses of NSAIDs should be used with caution in patients with atherosclerotic cardiovascular disease because they may deprive the heart of its innate defensive response.",
keywords = "Acetylsalicylic acid, Delayed preconditioning, NF-κB",
author = "Gabor Jancso and Barbara Cserepes and B. Gasz and Laszlo Benko and A. Ferencz and B. Borsiczky and J. Lantos and Anjali Dureja and Katalin Kiss and J. Szeber{\'e}nyi and E. Rőth",
year = "2005",
month = "9",
doi = "10.1097/01.fjc.0000175240.64444.68",
language = "English",
volume = "46",
pages = "295--301",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of acetylsalicylic acid on nuclear factor-κB activation and on late preconditioning against infarction in the myocardium

AU - Jancso, Gabor

AU - Cserepes, Barbara

AU - Gasz, B.

AU - Benko, Laszlo

AU - Ferencz, A.

AU - Borsiczky, B.

AU - Lantos, J.

AU - Dureja, Anjali

AU - Kiss, Katalin

AU - Szeberényi, J.

AU - Rőth, E.

PY - 2005/9

Y1 - 2005/9

N2 - Nuclear factor-κB (NF-κB) plays an essential role in the intracellular signal transduction of the second window of protection (SWOP). Acetylsalicylic acid (ASA) blocks NF-κB-dependent gene activation in leukocytes and endothelial cells through preventing phosphorylation and subsequent degradation of the inhibitor IκB-α. This study investigated the effect of ASA on the late phase of ischemic preconditioning (PC) against myocardial infarction and on the activation of NF-κB in the preconditioned myocardium. Conscious rabbits were subjected to 4 cycles of 5 minutes of coronary occlusion and 5 minutes of reperfusion together with 3 different doses of ASA (5 mg/kg; 25 mg/kg; 130 mg/kg). After 30 minutes of reperfusion we determined the activation of NF-κB with an electrophoretic mobility shift assay (EMSA). Twenty-four hours later, after 30 minutes of test ischemia, we performed infarct size analysis using triphenyltetrazolium-chloride (TTC) staining. Neither 5 mg/kg (antithrombotic dose) nor 25 mg/kg (analgesic/antipyretic dose) of ASA interfered with the NF-κB activation and the protective effect of late preconditioning against myocardial infarction. In contrast, NF-κB activation and late PC effect were completely abrogated by 130 mg/kg of ASA. Our results suggest that nonselective doses of NSAIDs should be used with caution in patients with atherosclerotic cardiovascular disease because they may deprive the heart of its innate defensive response.

AB - Nuclear factor-κB (NF-κB) plays an essential role in the intracellular signal transduction of the second window of protection (SWOP). Acetylsalicylic acid (ASA) blocks NF-κB-dependent gene activation in leukocytes and endothelial cells through preventing phosphorylation and subsequent degradation of the inhibitor IκB-α. This study investigated the effect of ASA on the late phase of ischemic preconditioning (PC) against myocardial infarction and on the activation of NF-κB in the preconditioned myocardium. Conscious rabbits were subjected to 4 cycles of 5 minutes of coronary occlusion and 5 minutes of reperfusion together with 3 different doses of ASA (5 mg/kg; 25 mg/kg; 130 mg/kg). After 30 minutes of reperfusion we determined the activation of NF-κB with an electrophoretic mobility shift assay (EMSA). Twenty-four hours later, after 30 minutes of test ischemia, we performed infarct size analysis using triphenyltetrazolium-chloride (TTC) staining. Neither 5 mg/kg (antithrombotic dose) nor 25 mg/kg (analgesic/antipyretic dose) of ASA interfered with the NF-κB activation and the protective effect of late preconditioning against myocardial infarction. In contrast, NF-κB activation and late PC effect were completely abrogated by 130 mg/kg of ASA. Our results suggest that nonselective doses of NSAIDs should be used with caution in patients with atherosclerotic cardiovascular disease because they may deprive the heart of its innate defensive response.

KW - Acetylsalicylic acid

KW - Delayed preconditioning

KW - NF-κB

UR - http://www.scopus.com/inward/record.url?scp=24344507660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344507660&partnerID=8YFLogxK

U2 - 10.1097/01.fjc.0000175240.64444.68

DO - 10.1097/01.fjc.0000175240.64444.68

M3 - Article

VL - 46

SP - 295

EP - 301

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 3

ER -